Posters

Clinical and functional features of congenital cataracts in children with myopia

Poster Details

First Author: D.Karimova UZBEKISTAN

Co Author(s):    L. Babadjanova   M. Mavlyanov                 

Abstract Details

Purpose:

Analysis of clinical and functional changes in cataracts in myopic eyes.

Setting:

The prognosis of the functional result of cataract extraction in myopic eyes also depends on the initial state of the eye membranes. Elongation, thinning, lengthening of the anterior-posterior axis is accompanied by a bleach of the microcirculation of eye tissues.

Methods:

An analysis of 15 (25 eyes) children with congenital cataracts combined with high myopia treated in the ophthalmology department of the clinic of the Tashkent Pediatric Medical Institute. Age ranged from 8 months to up to 11 years old. Boys accounted for 60% (9 children), girls -40% (6 children). Unilateral process was observed in 5 (33%), bilateral in 10 (67%). All children underwent standard examining methods.

Results:

The visual acuity before the operation was from light perception with the correct projection to 0.05; after surgical treatment from 0.06 to 0.3 (average 0.17 ± 0.12). The elongation of the anterior-posterior axis was noted in the range of 22.0-28.5 mm. Unevenness of the anterior chamber (usually a deepening) was detected in 7 (28%) eyes. Fundus ophthalmoscopy was performed intraoperatively. Parquet type was determined in 18 (72%) eyes, myopic optic disc cone in 20 (80%), blurring of normal reflexes in 16 (64%), translucent large vessels of the choroid in 18 (72%) eyes. Destruction of CT was established on B-scan in 15 (60%) eyes. Tonometry was within normal limits for all children.

Conclusions:

The features of the myopic eye are the stretching of the eye tissue, the destruction of the vitreous body which complicates the conduct of surgery and requires a differentiated approach to avoid intra and postoperative complications. A thorough approach to diagnostic research methods is a fairly serious prevention of possible complications.

Financial Disclosure:

None